Flatiron’s former CMO & CSO, Amy Abernethy, and Dr. Rick Pazdur of the FDA discuss the agency’s engagement with real-world evidence, the path forward for RWE, and the future of cancer care at the 2018 Flatiron Research Summit.
Flatiron Co-Founder Zach Weinberg and former CMO & CSO, Amy Abernethy, open the 2018 Flatiron Research Summit sharing their perspectives on the promise of real-world evidence.
Thought leaders from the FDA, life sciences and Flatiron real-world data experts discuss current and future uses of regulatory-grade RWE at the 2018 Flatiron Research Summit.
Discover how real-world endpoints are enabling new approaches and how Flatiron is partnering with regulatory and industry stakeholders to develop and validate them.
Flatiron's academic partners share their perspective on partnering with life sciences organizations on health outcomes research, and how RWE can be leveraged to drive greater collaboration.
Amy Abernethy speaks with Greg Simon of the Biden Cancer Initiative about opportunities for innovation in the current healthcare system in order to accelerate treatment options for cancer patients.
Flatiron team members discuss the evolving role of machine learning and natural language processing (NLP) in real-world evidence along with appropriate applications for these technologies.